Home539871 • BOM
add
Thyrocare Technologies Ltd
Nakaraang pagsara
₹783.90
Sakop ng araw
₹771.80 - ₹784.05
Sakop ng taon
₹555.85 - ₹1,053.05
Market cap
41.38B INR
Average na Volume
5.97K
P/E ratio
47.11
Dividend yield
2.31%
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.66B | 23.14% |
Gastos sa pagpapatakbo | 610.00M | 17.67% |
Net na kita | 191.10M | 24.50% |
Net profit margin | 11.52 | 1.14% |
Kita sa bawat share | 3.56 | — |
EBITDA | 342.68M | 31.98% |
Aktuwal na % ng binabayarang buwis | 32.13% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.38B | 38.47% |
Kabuuang asset | — | — |
Kabuuang sagutin | — | — |
Kabuuang equity | 4.89B | — |
Natitirang share | 52.99M | — |
Presyo para makapag-book | 8.58 | — |
Return on assets | — | — |
Return on capital | 12.16% | — |
Cash Flow
Net change in cash
| (INR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 191.10M | 24.50% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Itinatag
1996
Headquarters
Website
Mga Empleyado
1,693
